# Cianna Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cianna-medical

- Industry: Medical Devices & Equipment
- Headquarters: Aliso Viejo, US
- Website: www.ciannamedical.com
- Total disclosed funding: $34M
- Latest round: Series B (Jun 19, 2015)
- Investors on record: 7

## About

Cianna Medical, Inc. is a medical technology company that specializes in developing innovative solutions for breast cancer treatment, focusing on enhancing patient care through advanced techniques and targeted therapies.Cianna Medical, Inc. was founded in 2007 and is headquartered in Aliso Viejo, US. The company is focused on oncology solutions for breast cancer care. In October 2018, Merit Medical Systems, Inc. agreed to acquire Cianna Medical for USD 200 mn, which includes an upfront payment of USD 135 mn and additional performance-based payments. The firm has engaged in a total of 7 investment deals since its inception.Cianna Medical's core products include Accelerated Partial Breast Irradiation (APBI) therapy and wire-free tumor localization tools, designed to improve breast cancer treatment outcomes. The company targets healthcare professionals such as oncologists and radiologists, distributing products across North America, Europe, Asia, and the Middle East.Cianna Medical generates revenue primarily through sales of its oncology products to healthcare facilities using a direct sales model. The pricing structure may involve tiered pricing based on volume or long-term supply contracts, with clients including hospitals and outpatient oncology practices.Following the acquisition by Merit Medical Systems, Inc. in October 2018, Cianna Medical aims to enhance its product offerings and expand its market reach. The recent funding from the acquisition deal will support the development of new products and entry into additional geographic markets. The company plans to leverage the resources and expertise of Merit Medical to further innovate in breast cancer treatment solutions.

## Funding rounds

- Series B, Jun 19, 2015, $4M — Novo Holdings, Fog City Capital
- Series B, Mar 21, 2011, $12M — Saints Capital, Novo Holdings, Emergent Medical Ventures, Fog City Capital
- Series A, Mar 31, 2009, $10M — Saints Capital, MIC Capital, Emergent Medical Ventures, Fog City Capital
- Series A, Dec 20, 2007, $8M — Windamere Venture Partners, Fog City Capital, Biolucent, Inc.

## Investors

- Windamere Venture Partners (https://capitalatlas.ai/funds/windamere-venture-partners) — Series A
- Fog City Capital (https://capitalatlas.ai/funds/fog-city-capital) — Series A, Series B
- Biolucent, Inc. — Series A
- Saints Capital (https://capitalatlas.ai/funds/saints-capital) — Series A, Series B
- MIC Capital — Series A
- Emergent Medical Ventures (https://capitalatlas.ai/funds/emergent-medical-ventures) — Series A, Series B
- Novo Holdings — Series B